c-erbB-2 oncogene product expression and prognosis in gastric carcinoma.
AUTOR(ES)
Hilton, D. A.
RESUMO
The prognostic value of c-erbB-2 protein expression was assessed retrospectively in 87 "curative" gastrectomy specimens from patients with gastric carcinoma. Tumours were stained immunohistochemically with the specific antibody 21N. Eight (9%) cases had strong membrane staining, all of which were of the intestinal type, and lymph node metastases, which showed concordance of staining in seven cases. In contrast to studies in breast cancer, positive cases showed a trend towards better five year survival, but this did not reach significance.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=495317Documentos Relacionados
- Lack of c-erbB-2 oncoprotein expression in male breast carcinoma.
- Prognostic value of c-erbB-2 expression in uterine cervical carcinoma.
- c-erbB-2 expression in different histological types of invasive breast carcinoma.
- Expression of c-erbB-2 oncogene product in Barrett's adenocarcinoma: pathological and prognostic correlations.
- c-erb-B-2 expression in male breast carcinoma.
